SEC Form N-PORT · 2026-03-31
FBT ETF Holdings
First Trust NYSE Arca Biotechnology Index Fund reported 32 holdings. Weights reproduce the source and may not sum to exactly 100 because of cash, derivatives, rounding, liabilities, or other positions.
- Report date
- 2026-03-31
- SEC accession
- 0000940400-26-021488
- Series ID
- S000012478
- Source
- SEC Form N-PORT
All reported holdings
| Ticker | Issuer | Weight | Value (USD) | Balance |
|---|---|---|---|---|
| MRNA | Moderna Inc | 5.261478% | 119,445,481.2 | 2,351,289 NS |
| UTHR | United Therapeutics Corporation | 4.358145% | 98,938,120.02 | 166,849 NS |
| ALKS | Alkermes PLC | 4.235159% | 96,146,103.04 | 2,719,064 NS |
| GILD | Gilead Sciences Inc. | 4.088616% | 92,819,305.04 | 665,992 NS |
| AXSM | Axsome Therapeutics Inc. | 3.885484% | 88,207,819.56 | 521,878 NS |
| AMGN | Amgen Inc. | 3.832568% | 87,006,523.55 | 247,283 NS |
| CORT | Corcept Therapeutics Inc. | 3.818702% | 86,691,734.06 | 2,150,626 NS |
| KRYS | Krystal Biotech Inc | 3.510402% | 79,692,753.28 | 308,504 NS |
| BIIB | Biogen Inc | 3.471295% | 78,804,950.49 | 429,853 NS |
| EXEL | Exelixis, Inc. | 3.459764% | 78,543,170.3 | 1,831,270 NS |
| NBIX | Neurocrine Biosciences Inc | 3.446577% | 78,243,811.24 | 593,926 NS |
| REGN | Regeneron Pharmaceuticals, Inc. | 3.445926% | 78,229,027.36 | 101,249 NS |
| VRTX | Vertex Pharmaceuticals Incorporated | 3.419268% | 77,623,834.36 | 173,834 NS |
| BMRN | Biomarin Pharmaceutical Inc. | 3.404148% | 77,280,579.6 | 1,368,040 NS |
| ARGX | Argenx SE | 3.291481% | 74,722,831.25 | 102,325 NS |
| SRPT | Sarepta Therapeutics Inc | 3.24393% | 73,643,325.44 | 3,384,344 NS |
| HALO | Halozyme Therapeutics Inc | 3.168153% | 71,923,043.09 | 1,112,843 NS |
| BNTX | BioNTech SE | 3.162264% | 71,789,353.68 | 807,711 NS |
| INCY | Incyte Corporation. | 3.128633% | 71,025,869.72 | 754,631 NS |
| ONC | BEONE MEDICINES LTD | 3.122138% | 70,878,423.84 | 238,672 NS |
| ILMN | Illumina Inc | 3.104216% | 70,471,563.06 | 571,731 NS |
| NTRA | NATERA INC | 3.032178% | 68,836,158.02 | 344,198 NS |
| ACAD | Acadia Pharmaceuticals Inc | 2.952877% | 67,035,878.7 | 3,011,495 NS |
| ALNY | Alnylam Pharmaceuticals Inc. | 2.951232% | 66,998,528.04 | 202,492 NS |
| TECH | Bio-Techne Corp | 2.825891% | 64,153,069.5 | 1,227,575 NS |
| GMAB | Genmab As | 2.782074% | 63,158,329.77 | 2,354,019 NS |
| VCYT | Veracyte Inc | 2.72179% | 61,789,763.61 | 1,918,341 NS |
| RGEN | Repligen Corporation | 2.508958% | 56,958,076.06 | 483,433 NS |
| BRKR | Bruker Corporation | 2.356233% | 53,490,938.76 | 1,480,923 NS |
| NEO | Neogenomics Inc | 2.002997% | 45,471,822.76 | 6,128,278 NS |
| MISXX | Dreyfus Government Cash Management Funds | 0.062285% | 1,413,994.11 | 1,413,994.11 NS |
| DAIWA CAPITAL MARKETS AMERICA INC. | DAIWA CAPITAL MARKETS AMERICA INC. | 0.008303% | 188,488 | 188,488 PA |